155 related articles for article (PubMed ID: 6376318)
1. The role of MOPP chemotherapy in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):66-9. PubMed ID: 6376318
[No Abstract] [Full Text] [Related]
2. Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):69-72. PubMed ID: 6547403
[No Abstract] [Full Text] [Related]
3. Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Fuller LM; Hagemeister FB
Recent Results Cancer Res; 1989; 117():197-204. PubMed ID: 2602645
[No Abstract] [Full Text] [Related]
4. The role of chemotherapy in the management of early stage Hodgkin's disease.
Rosenberg SA
Hematol Oncol; 1984; 2(1):61-3. PubMed ID: 6203821
[No Abstract] [Full Text] [Related]
5. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
6. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
7. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Canellos GP
Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
[No Abstract] [Full Text] [Related]
8. MOPP, ABVD, or both to treat Hodgkin's disease.
Aisenberg AC
N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
[No Abstract] [Full Text] [Related]
9. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
10. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Bakemeier RF; Anderson JR; Costello W; Rosner G; Horton J; Glick JH; Hines JD; Berard CW; DeVita VT
Ann Intern Med; 1984 Oct; 101(4):447-56. PubMed ID: 6089632
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
Blijham GH; Vermeulen A; Mendes de Leon DE
Cancer; 1985 Nov; 56(9):2292-4. PubMed ID: 3840407
[TBL] [Abstract][Full Text] [Related]
12. Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
Wells JD; Huskison WT; Davenport OL
South Med J; 1986 Oct; 79(10):1293-6. PubMed ID: 3464101
[TBL] [Abstract][Full Text] [Related]
13. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
Casini M; Pianezze G; Fabris P; Cemin S; Coser P
Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
[No Abstract] [Full Text] [Related]
14. Current management of Hodgkin's disease.
Behrens BC; Young RC; DeVita VT
Drugs; 1985 Oct; 30(4):355-67. PubMed ID: 3905335
[TBL] [Abstract][Full Text] [Related]
15. The intergroup Hodgkin's disease in children. A study of stages I and II.
Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
[TBL] [Abstract][Full Text] [Related]
16. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
[TBL] [Abstract][Full Text] [Related]
17. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
18. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
Tombolini V; Capua A; Pompili E
Acta Oncol; 1992; 31(1):64-5. PubMed ID: 1375043
[No Abstract] [Full Text] [Related]
19. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
[TBL] [Abstract][Full Text] [Related]
20. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
da Cunha MF; Meistrich ML; Fuller LM; Cundiff JH; Hagemeister FB; Velasquez WS; McLaughlin P; Riggs SA; Cabanillas FF; Salvador PG
J Clin Oncol; 1984 Jun; 2(6):571-7. PubMed ID: 6547167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]